Similar Items: In vitro study of in silico designed sirtuin 1 and bromodomain 4 inhibitors on human neuroblastoma SH-SY5Y and acute myeloid leukemia U937 cells
- Evaluation of the neurotoxicity of pentachlorophenol and its active metabolites on SH-SY5Y neuroblastoma cells
- The effect of selected medicinal plants on rotenone-induced toxicity in SH-SY5Y neuroblastoma cells
- Assessing the effects of two plants containing psychoactive compounds on the SH-SY5Y Parkinson’s disease neuroblastoma cell model
- In vitro effect of a sirtuin inhibitor and its possible synergistic effect with a potential tubulin inhibitor on breast cancer cell lines
- High throughput in silico screening and in vitro testing of polypharmacological bromodomain 4 and cancer associated kinase inhibitors
- Comparison of differentiation protocols of SH-SY5Y cells for use as an in vitro model of Alzheimer’s disease
Similar Items: Evaluation of a strategy based on multi-drug targeting of cancer proteins in breast cancer cell lines
- In vitro effect of a sirtuin inhibitor and its possible synergistic effect with a potential tubulin inhibitor on breast cancer cell lines
- Characterization of a polypeptide factor that inhibits the growth of a human breast cancer line in vitro
- Development of a breast cancer spheroid model for use in drug discovery and cancer biology research
- Metabolic control analysis using glycolytic inhibitor titrations in the MCF-7 breast cancer cell line
- In vitro signal transduction mechanism exerted by 2-ethyl-3-O-sulphamoyl-estra-1,3,5(10),15-tetraen-3-ol-17-one in combination with dichloroacetic acid on breast adenocarcinoma (MCF-7) and breast non-tumorigenic (MCF-12A) cells
- Improving breast cancer therapy through oestrone analogue and glycolysis inhibitor synergism